Gates Package — page 193

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl Foundation for the National Institutes of Health, Inc. (FNIH), iThemba Pharmaceuticals (Pty) Ltd [ZA], Stellenbosch University (Universiteit Stellenbosch) [ZA], University of Cambridge ( The Chancellor, Masters, and Scholars of the Universit, University of Cape Town (UCT) [ZA], University of Dundee [GB], University of the Witwatersrand (Wits 2011-19356 _ I Research Collaboration Agreement 6/27/2012 University) [ZA] Clifton Barry RIKEN Research Center for Allergy and Immunology 2011-2272 Research Collaboration Agreement 7/6/2012] 3/31/2017|(RCAI) [JP] Ronald Germain 2011-2853 CTA - Clinical Trial Agreement 4/16/2012 Quintiles, Inc., Tobira Therapeutics lrini Sereti US Fish and Wildlife Service, Department of the 2011-6009 Gift 12/5/2011 Interior Ronald Germain 2011-8242 Research Collaboration Agreement 4/17/2012} _4/17/2023|Merck Sharp & Dohme Corp Michael Lenardo 2012_32517. |CRADA 4/15/2014] 10/5/2017|GeoVax, Inc. Bernard Moss Jane Coffin Childs Memorial Fund for Medical 2012-0095 Gift 2/17/2012 Research Ronald Germain RIKEN (The Institute of Physical and Chemical Research) [JP], RIKEN Research Center for Allergy 2012-0112 Gift 7/19/2012] 3/31/2017} and Immunology (RCAI) [JP] Ronald Germain 2012-0222 Gift 3/5/2012 American Asthma Foundation [US] Joshua Milner RIKEN (The Institute of Physical and Chemical Research) [JP], RIKEN Research Center for Allergy 2012-0245 Gift 7/19/2012| _3/31/2024]and Immunology (RCAI) [JP] Ronald Germain RIKEN (The Institute of Physical and Chemical 2012-0245 Gift 7/19/2012] 3/31/2024]Research) [JP] Ronald Germain RIKEN (The Institute of Physical and Chemical Research) [JP], RIKEN Research Center for Allergy 2012-0245 Gift 7/19/2012] _ 3/31/2024] and Immunology (RCAI) [JP] Ronald Germain 2012-0324 CRADA 1/8/2014] 1/8/2017] Regeneron Pharmaceuticals, Inc. Michael Lenardo 2012-0447 CTA - Clinical Trial Agreement 6/21/2012| Gilead Sciences, Inc 2012-0447 CTA - Clinical Trial Agreement 6/21/2012 Gilead Sciences, Inc 2012-0448 CTA - Clinical Trial Agreement 8/23/2012 Gilead Sciences, Inc Shyamasundaran